Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 4
2010 2
2011 4
2012 2
2013 2
2014 3
2015 3
2016 2
2017 6
2018 3
2019 7
2020 10
2021 22
2022 15
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Authors' Reply.
Clarke CL, Prendecki M, McAdoo SP, Willicombe M. Clarke CL, et al. Among authors: willicombe m. J Am Soc Nephrol. 2020 Dec;31(12):2967-2968. doi: 10.1681/ASN.2020091276. Epub 2020 Sep 29. J Am Soc Nephrol. 2020. PMID: 33001841 Free PMC article. No abstract available.
Renal transplantation.
Thiruchelvam PT, Willicombe M, Hakim N, Taube D, Papalois V. Thiruchelvam PT, et al. Among authors: willicombe m. BMJ. 2011 Nov 14;343:d7300. doi: 10.1136/bmj.d7300. BMJ. 2011. PMID: 22084316 Review. No abstract available.
Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence.
Gisby JS, Buang NB, Papadaki A, Clarke CL, Malik TH, Medjeral-Thomas N, Pinheiro D, Mortimer PM, Lewis S, Sandhu E, McAdoo SP, Prendecki MF, Willicombe M, Pickering MC, Botto M, Thomas DC, Peters JE. Gisby JS, et al. Among authors: willicombe m. Nat Commun. 2022 Dec 15;13(1):7775. doi: 10.1038/s41467-022-35454-4. Nat Commun. 2022. PMID: 36522333 Free PMC article.
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Barnes E, Goodyear CS, Willicombe M, Gaskell C, Siebert S, I de Silva T, Murray SM, Rea D, Snowden JA, Carroll M, Pirrie S, Bowden SJ, Dunachie SJ, Richter A, Lim Z, Satsangi J, Cook G, Pope A, Hughes A, Harrison M, Lim SH, Miller P, Klenerman P; PITCH consortium; Basu N, Gilmour A, Irwin S, Meacham G, Marjot T, Dimitriadis S, Kelleher P, Prendecki M, Clarke C, Mortimer P, McIntyre S, Selby R, Meardon N, Nguyen D, Tipton T, Longet S, Laidlaw S, Orchard K, Ireland G; CONSENSUS; Thomas D, Kearns P, Kirkham A, McInnes IB; OCTAVE Collaborative Group. Barnes E, et al. Among authors: willicombe m. Nat Med. 2023 Jul;29(7):1760-1774. doi: 10.1038/s41591-023-02414-4. Epub 2023 Jul 6. Nat Med. 2023. PMID: 37414897 Free PMC article.
Single-dose SARS-CoV-2 vaccination efficacy in the elderly.
Prendecki M, Willicombe M. Prendecki M, et al. Among authors: willicombe m. Lancet Infect Dis. 2021 Nov;21(11):1474-1475. doi: 10.1016/S1473-3099(21)00354-6. Epub 2021 Jun 23. Lancet Infect Dis. 2021. PMID: 34174192 Free PMC article. No abstract available.
SARS-CoV-2 vaccine strategies in kidney transplant recipients.
Prendecki M, Willicombe M. Prendecki M, et al. Among authors: willicombe m. Lancet Infect Dis. 2023 Mar;23(3):263-264. doi: 10.1016/S1473-3099(22)00666-1. Epub 2022 Oct 27. Lancet Infect Dis. 2023. PMID: 36354033 Free PMC article. No abstract available.
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients.
Carr EJ, Wu M, Harvey R, Billany RE, Wall EC, Kelly G; Haemodialysis COVID-19 Consortium, Crick COVID Immunity Pipeline; Howell M, Kassiotis G, Swanton C, Gandhi S, Bauer DL, Graham-Brown MP, Jones RB, Smith RM, McAdoo S, Willicombe M, Beale R. Carr EJ, et al. Among authors: willicombe m. Lancet. 2022 Feb 26;399(10327):800-802. doi: 10.1016/S0140-6736(22)00104-0. Epub 2022 Jan 20. Lancet. 2022. PMID: 35065703 Free PMC article. No abstract available.
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease.
Liew F, Efstathiou C, Fontanella S, Richardson M, Saunders R, Swieboda D, Sidhu JK, Ascough S, Moore SC, Mohamed N, Nunag J, King C, Leavy OC, Elneima O, McAuley HJC, Shikotra A, Singapuri A, Sereno M, Harris VC, Houchen-Wolloff L, Greening NJ, Lone NI, Thorpe M, Thompson AAR, Rowland-Jones SL, Docherty AB, Chalmers JD, Ho LP, Horsley A, Raman B, Poinasamy K, Marks M, Kon OM, Howard LS, Wootton DG, Quint JK, de Silva TI, Ho A, Chiu C, Harrison EM, Greenhalf W, Baillie JK, Semple MG, Turtle L, Evans RA, Wain LV, Brightling C, Thwaites RS, Openshaw PJM; PHOSP-COVID collaborative group; ISARIC investigators. Liew F, et al. Nat Immunol. 2024 Apr;25(4):607-621. doi: 10.1038/s41590-024-01778-0. Epub 2024 Apr 8. Nat Immunol. 2024. PMID: 38589621 Free PMC article.
86 results